1.5TMRI
|
1.5 Tesla magnetic resonance imaging |
3TMRI
|
3 Tesla magnetic resonance imaging |
AD
|
Alzheimer’s disease |
ADC
|
Apparent diffusion coefficient |
ALS
|
Amyotrophic lateral sclerosis |
BOLD
|
Blood oxygen level dependent |
Cho
|
Choline |
CMS
|
Cervical myelopathy scale |
CR
|
Compression Ratio |
Cr
|
Creatine |
CSM
|
Cervical spondylotic myelopathy |
CT
|
Computed tomography |
DBSI
|
Diffusion basis spectrum imaging |
DCM
|
Degenerative cervical myelopathy |
DNA
|
Deoxyribonucleic acid |
DTI
|
Diffusion tensor imaging |
DTT
|
Diffusion tensor tractography |
DWI
|
Diffusion weighted imaging |
EMG
|
Electromyography |
EMS
|
European myelopathy scale |
FA
|
Fractional anisotropy |
FC
|
Functional connectivity |
fFOV
|
Full field of view |
fMRI
|
Functional MRI |
Glx
|
Glutamate-glutamine |
Ins
|
Myo-inositols |
MCC
|
Maximum canal compromise |
MEPs
|
Motor evoked potentials |
mJOA
|
Modified Japanese Orthopaedic Association scale |
MRI
|
Magnetic resonance imaging |
MRS
|
Magnetic resonance spectroscopy |
MS
|
Multiple sclerosis |
MSCC
|
Maximum spinal cord compression |
MT
|
Magnetization transfer |
MTR
|
Magnetization transfer ratio |
MWF
|
Myelin water fraction |
NAA
|
N-acetylaspartate |
NCS
|
Nerve conduction studies |
NDI
|
Neck disability index |
NPRS
|
Numeric pain rating scale |
OPLL
|
Ossification of the posterior longitudinal ligaments |
PD
|
Parkinson’s disease |
qMRI
|
Quantitative magnetic resonance imaging |
QSM
|
Quantitative susceptibility mapping |
R2*MRI
|
R2* magnetic resonance imaging |
rFOV
|
Reduced field of view |
ROI
|
Region of interest |
SMA
|
Supplementary motor area |
SSEPs
|
Somatosensory evoked potentials |
SWI
|
Susceptibility weighted imaging |
T1WI
|
T1 weighted imaging |
T2*WI
|
T2*-weighted imaging |
T2WI
|
T2 weighted imaging |
VOA
|
Volume of activation |